Atrial fibrillation deteriorates tricuspid regurgitation following implantable cardioverter defibrillator lead placement in patient with hypertrophic obstructive cardiomyopathy
| Autor: | Tatsuya Murai, Mike Saji, Morimasa Takayama, Takato Mohri |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
implantable cardioverter defibrillator medicine.medical_treatment Population heart failure Autopsy Case Report Regurgitation (circulation) Case Reports 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine autopsy Internal medicine hypertrophic obstructive cardiomyopathy Medicine 030212 general & internal medicine education tricuspid regurgitation education.field_of_study business.industry Atrial fibrillation Implantable cardioverter-defibrillator medicine.disease medicine.anatomical_structure Ventricle Heart failure Cardiology Cardiology and Cardiovascular Medicine business Lead Placement |
| Zdroj: | Journal of Arrhythmia |
| ISSN: | 1883-2148 1880-4276 |
| Popis: | Although atrial fibrillation (AF) often exists in patients with hypertrophic obstructive cardiomyopathy (HOCM), combination of tricuspid regurgitation (TR) and AF after implantation of pacemaker/implantable cardioverter defibrillator (ICD) lead and its optimal management have not been well discussed in this population. Herein, we present a patient with HOCM who subsequently died due to severe heart failure and deterioration of TR following ICD lead placement with AF. Autopsy findings demonstrated that ICD leads were entrapped by anomaly structure in the right atrium and ventricle, which might affect deterioration of TR. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text